Jiangsu HengRui Medicine Co., Ltd.: Glomerulonephritis, IGA trials
The registry lists 10 Glomerulonephritis, IGA studies with Jiangsu HengRui Medicine Co., Ltd. as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 1 4Phase 2 5Phase 3 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA NephropathyRecruitingNCT07582133Phase 2
- A Study of SHR-2173 in Participants With Primary IgA NephropathyRecruitingNCT07354932Phase 2
- A Trial of HRS-5965 Capsule in Primary IgA NephropathyRecruitingNCT07014826Phase 3
- A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy SubjectsCompletedNCT07035665Phase 1
- Relative Bioavailability Study of HR19042 in Healthy SubjectsCompletedNCT06922305Phase 1
- A Trial of HRS-5965 Tablets in Primary IgA NephropathyCompletedNCT06137768Phase 2
- Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA NephropathyTerminatedNCT05847920Phase 2
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy SubjectCompletedNCT05398510Phase 1
- A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.CompletedNCT05016323Phase 2
- A Trial of HR19042 Capsule in Healthy Chinese SubjectsCompletedNCT04887532Phase 1